GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » YoY Rev. per Sh. Growth

ATAI Life Sciences NV (MEX:ATAI) YoY Rev. per Sh. Growth : -100.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ATAI Life Sciences NV YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ATAI Life Sciences NV's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was -100.00%.

ATAI Life Sciences NV's Revenue per Share for the three months ended in Mar. 2024 was MXN0.00.

ATAI Life Sciences NV YoY Rev. per Sh. Growth Historical Data

The historical data trend for ATAI Life Sciences NV's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV YoY Rev. per Sh. Growth Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- - - -99.04 17.24

ATAI Life Sciences NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -13.64 200.00 -60.00 -100.00

ATAI Life Sciences NV YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ATAI Life Sciences NV's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.034-0.029)/ | 0.029 |
=17.24 %

ATAI Life Sciences NV's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(0-0.004)/ | 0.004 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ATAI Life Sciences NV YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV (MEX:ATAI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
LCTX RENB AEON FATE ZURA IMRX HUMA ENTA SCPH CRMD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ATAI:USA 9VC:Germany
Address
Wallstraße 16, Berlin, BB, DEU, 10179
Website
https://www.atai.life
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.